Related Experiment Video
Updated: Feb 8, 2026

Culture of Bladder Cancer Organoids as Precision Medicine Tools
Published on: December 28, 2021
Abstract:
Findings from a phase II study indicate clinical efficacy with erdafitinib in patients with FGFR-altered inoperable or metastatic urothelial carcinoma. Robust responses were seen with this investigational pan-FGFR inhibitor, including in patients who did not respond to prior immunotherapy.
Insights
Erdafitinib shows clinical efficacy in patients with advanced urothelial carcinoma harboring fibroblast growth factor receptor alterations. This pan-FGFR inhibitor demonstrated robust responses, even in patients previously unresponsive to immunotherapy.
Area of Science:
- Oncology
- Medical Genetics
Background:
- Urothelial carcinoma is a significant cause of cancer mortality.
- Fibroblast growth factor receptor (FGFR) alterations are implicated in urothelial carcinoma pathogenesis.
- Targeted therapies offer a promising avenue for treatment.
Discussion:
- Erdafitinib, a pan-FGFR inhibitor, was investigated in a phase II study for advanced urothelial carcinoma.
- The study assessed clinical efficacy and response rates in patients with FGFR alterations.
- Prior treatment history, including immunotherapy response, was considered.
Key Insights:
- Erdafitinib demonstrated clinical efficacy in patients with FGFR-altered inoperable or metastatic urothelial carcinoma.
- Robust treatment responses were observed with erdafitinib.
- Efficacy was noted even in patients who had not responded to prior immunotherapy.
Outlook:
- Erdafitinib represents a potential therapeutic option for a specific subset of urothelial carcinoma patients.
- Further investigation may explore its role in combination therapies or earlier lines of treatment.
- Personalized medicine approaches targeting FGFR alterations are advancing cancer care.
More Related Videos
06:12Evaluation of the Efficacy of the H. pylori Protein HP-NAP as a Therapeutic Tool for Treatment of Bladder Cancer in an Orthotopic Murine Model
Published on: May 29, 2015
09:243-D Cell Culture System for Studying Invasion and Evaluating Therapeutics in Bladder Cancer
Published on: September 13, 2018
Related Concept Videos
Self-Efficacy
Urinary Bladder
In males, the bladder is situated in front of the rectum, while in females, it is positioned anterior to the vagina and uterus. The bladder floor contains an inverted triangular area called the trigone, defined by the two ureteric...
Anatomy of the Genitourinary System II: Bladder and Urethra
Imaging Studies I: Kidney, Ureter, and Bladder Studies
Dose-Response Relationship: Potency and Efficacy
Cancer